KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Medtronic (MDT) Shares Outstanding (2017 - 2026)

Medtronic's Shares Outstanding history spans 14 years, with the latest figure at $1.3 billion for Q1 2026.

  • On a quarterly basis, Shares Outstanding changed 0.03% to $1.3 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $1.3 billion, a 0.03% change, with the full-year FY2025 number at $1.3 billion, down 2.22% from a year prior.
  • Shares Outstanding hit $1.3 billion in Q1 2026 for Medtronic, roughly flat from $1.3 billion in the prior quarter.
  • Over the last five years, Shares Outstanding for MDT hit a ceiling of $1.3 billion in Q1 2022 and a floor of $1.3 billion in Q2 2025.
  • Historically, Shares Outstanding has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2022.
  • Biggest five-year swings in Shares Outstanding: grew 0.08% in 2023 and later dropped 3.61% in 2024.
  • Tracing MDT's Shares Outstanding over 5 years: stood at $1.3 billion in 2022, then changed by 0.0% to $1.3 billion in 2023, then fell by 3.53% to $1.3 billion in 2024, then decreased by 0.08% to $1.3 billion in 2025, then grew by 0.11% to $1.3 billion in 2026.
  • Business Quant data shows Shares Outstanding for MDT at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.